Major trial aims to spare thousands from chemotherapy
NCT ID NCT07213206
Summary
This large study is testing if a combination of newer, targeted drugs can effectively control a specific type of early-stage breast cancer, potentially allowing patients to avoid traditional chemotherapy. It will compare the new drug regimen against the standard approach of chemotherapy plus targeted therapy in 1500 women. The goal is to find a treatment that works just as well but with fewer harsh side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.